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Aim. To explore the efficacy of home-based, computerised, cognitive rehabilitation in patients with multiple sclerosis using
neuropsychological assessment and advanced structural and functional magnetic resonance imaging (fMRI).Methods. 38 patients
withMS and cognitive impairment on the Brief International Cognitive Assessment forMS (BICAMS) were enrolled. Patients were
randomised to undergo 45 minutes of computerised cognitive rehabilitation using RehaCom software (𝑛 = 19) three times weekly
for six weeks or to a control condition (𝑛 = 19). Neuropsychological and MRI data were obtained at baseline (time 1), following
the 6-week intervention (time 2), and after a further twelve weeks (time 3). Cortical activations were explored using fMRI and
microstructural changes were explored using quantitative magnetisation transfer (QMT) imaging. Results. The treatment group
showed a greater improvement in SDMT gain scores between baseline and time 2 compared to the control group (𝑝 = 0.005).
The treatment group exhibited increased activation in the bilateral prefrontal cortex and right temporoparietal regions relative to
control group at time 3 (𝑝 < 0.05FWE corrected). No significant changes were observed on QMT. Conclusion. This study supports
the hypothesis that home-based, computerised, cognitive rehabilitation may be effective in improving cognitive performance in
patients with MS. Clinical trials registration is ISRCTN54901925.
1. Introduction
Cognitive impairment is present in 40–65% of individuals
with MS [1]. Studies have shown cognitive deficits (in partic-
ular deficits in information processing speed, concentration,
and working memory) to be present in the early stages of MS
[2–4]. Cognitive impairment has a negative impact on quality
of life (QOL) independent of physical symptoms [5, 6].
There exists mounting evidence for neuroplasticity as a
mechanism to compensate for accumulating pathology inMS
and some tentative evidence that cognitive rehabilitationmay
be effective in preserving or improving cognitive function
in patients with MS [7–9]. Computer-assisted cognitive
rehabilitation has the potential to provide a structured and
standardised approach to rehabilitation. RehaCom is one par-
ticular type of software designed and utilised for treatment
of cognitive impairment in a number of disease states such
as stroke, brain injury, and psychiatric disorders [10, 11]. It
has been used in a growing number of trials of cognitive
rehabilitation in MS as a more standardised intervention [8,
9, 12, 13].The difficulty level of the computerised tasks adapts
to an individual’s performance, only increasing in difficulty
in response to improving performance.
Few studies have examined the structural basis of cog-
nitive rehabilitation and longitudinal studies are relatively
lacking [8, 14]. Animal data suggest that myelination is, at
least in part, regulated by neuronal activity [15]. It is therefore
conceivable that techniques, such as magnetisation transfer
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(MT), which is sensitive tomyelin content, might be sensitive
to structural plasticity in MS [16].
In this study we combined neuropsychological assess-
ment, functional MRI (fMRI), and quantitative magneti-
sation transfer (QMT) imaging to explore whether home-
based, computerised cognitive rehabilitation is an effective
means of promoting cognitive rehabilitation and whether
the structural basis for rehabilitation can be better defined
[17]. The primary outcome of the study was measured as
any improvement in cognition after the training, while the
secondary outcomes included changes in fMRI, fatigue, and
quality of life assessments.
2. Subjects and Method
Participants. Thirty-eight patients with objective evidence of
cognitive impairment were invited to participate in this study
between February 2014 and February 2015. All participants
signed informed written consent before undergoing testing.
Inclusion criteria were as follows: (a) age between 18 and 65,
(b) clinically definiteMS, according to theMcDonald criteria
[18], (c) Expanded Disability Status Scale (EDSS) ≤ 6.5, and
(d) cognitive impairment defined as scores below the 5th
percentile for normative data adjusted for age, sex, and years
of formal education [19] on one ormore of the BICAMS tests.
Patients were excluded if they had a history of significant
psychiatric disorders, alcohol or substance abuse, visual acu-
ity less than 6/18 corrected, oscillopsia, or diplopia that would
interfere with testing. Patients were also excluded if they had
a MS relapse, received corticosteroids, or changes made to
psychoactive medications within the previous month.
The studywas approved by theNorthern IrelandResearch
Ethics Committee.
Study Design. An open-design, randomised, controlled trial
was conducted. Neuropsychological and MRI data were
obtained at baseline (time 1), immediately following a 6-week
intervention period (time 2) and after an additional 12-week
follow-up period (time 3), during which no additional inter-
vention was administered (supplementary Figure 1 in Supple-
mentaryMaterial available online at http://dx.doi.org/10.1155/
2016/4292585).
It was not possible for the cognitive assessments to be
completed by a blinded assessor. The MRI analysis was con-
ducted by a researcher blind to the patients’ group allocation.
Cognitive and Behavioural Assessments. At entry all partici-
pants underwent a detailed clinical neurological assessment
including EDSS conducted by an experienced neurologist.
Patients were screened for cognitive impairment using the
Brief International Cognitive Assessment for MS (BICAMS).
BICAMS is a brief (15-minute) screening tool to identify
cognitive impairment in patients with MS and comprises the
first five learning trials of the California Verbal Learning Test
II (CVLT-II), the first three recall trials of Brief Visuospatial
Memory Test Revised (BVMT-R), and the Symbol Digits
Modalities Test (SDMT) [20].
The BICAMS assessment was conducted by a neurology
clinical fellow with almost ten years of clinical experience
(J.C). The assessing neurologist was trained in BICAMS
assessing methods by an experienced neuropsychologist
(D.L).
At baseline participants also completed a number of
behavioural and QOL assessments including EuroQOL five-
dimension questionnaire (EQ-5D), a generic health-related
quality of life scale [21], Functional Assessment of MS
(FAMS) (a MS specific quality of life scale) [22], Patient Acti-
vationMeasure (PAM-13) (a 13-item generic scale for chronic
illness management), a measure of patient “empowerment”
in MS [23], Unidimensional Self-Efficacy scale for MS (USE-
MS) [24], theHospital Anxiety andDepression Scale (HADS)
[25], Multiple Sclerosis Neuropsychological Questionnaire
(MSNQ) self-report (a patient self-reported measure of cog-
nitive function) [26], and the Fatigue Severity Scale [27].
At each subsequent time point participants underwent
repeat cognitive assessment using BICAMS (same test forms)
as well as repeat behavioural and QOL assessments.
Randomisation. Following baseline MRI, patients were ran-
domised to either the treatment or control groups. Randomi-
sation was performed using a random number generator and
allocations were placed inside sealed folders. Folders were
opened following baseline MRI.
Intervention. The treatment group underwent six weeks
of home-based, computer-assisted cognitive rehabilitation
using RehaCom software (https://www.fixxl.co.uk/). This
consisted of 45-minute sessions, three times weekly. The
control group were asked to watch a series of natural history
DVDs of corresponding duration and frequency to the
rehabilitation sessions performed by the treatment group for
six weeks. The need to evaluate MRI parameters in studies
with active control conditions has been highlighted [14].
Treatment sessions consisted of training in three specific
modules involving working memory, visuospatial memory,
and divided attention. In all tasks the level of difficulty
is tailored to the individuals performance and increases
automatically but only in line with satisfactory progress.
Real-time data pertaining to performance, progress, and
compliance is transmitted to the investigator over the Internet
during the intervention period.
“Divided Attention” Module. In the divided attention task
the patient is asked to drive a simulated car using keyboard
inputs. Multiple distractions must be navigated and the
speed and direction of the vehicle altered according to road
conditions. As the complexity of the task increases, more
distractors are introduced with increased multitasking skills
required.
“Working Memory” Module. The working memory task con-
sists of remembering a series of playing cards presented
briefly on screen.The participant is then asked to select which
cardswere presented froma longer series of options including
distractor cards. As the complexity of the task increases,
participants are asked to remember only cards of a particular
value or suit and the number of items to remember increases.
Higher levels involve having to remember the cards in reverse
order.
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“Topological Memory” Module. Visuospatial memory is a
similar task involving various objects presented briefly on
screen with the patient asked to remember the object as well
as its position in the sequence. As the complexity of the task
increases, the number of items on screen increases and more
abstract shapes are introduced.
MRI Imaging Protocol. The following sequences were
acquired in an order designed to minimise the potential
for fatigue on the fMRI task: (1) dual-echo turbo spin-echo
for lesion identification; (2) high-resolution T1-weighted
magnetisation-prepared rapid-acquisition gradient echo
(MPRAGE); (3) functional MRI with echo-planar imaging
(EPI) acquired during a 𝑛-visually presented back task; (4)
quantitative magnetisation transfer (QMT) with balanced
steady-state free precession (bSSFP) [28].
T2 lesion volume was measured at baseline for each par-
ticipant using the software package JIM (Version 3.0, Xinapse
Systems Ltd., Northamptonshire, UK, http://www.xinapse
.com/).
𝑁-Back Task. A visual 𝑛-back test was presented during
functional imaging acquisition.This was adapted from Sweet
et al. [29] and involved three conditions: 0-back, 1-back, and
2-back tasks.The 0-back condition was designed to act as the
baseline condition and would provide the baseline activation
for comparison in fMRI analysis. The 1-back and 2-back
conditions provided increasing working memory demands.
The 𝑛-back task did not constitute part of the cognitive
rehabilitation. All participants were allowed to briefly prac-
tice the 𝑛-back task under supervision for five minutes prior
to the MRI scan to ensure comprehension of the task and
allow familiarity with it.
The visual 𝑛-back task was presented using Cogent V
and MATLAB 2013a. Stimuli were projected onto a mirrored
screen inside the MRI scanner 45 cm from a participant’s
nose. An MRI compatible button box was placed in the
participant’s right hand.
White letters were projected onto a black background
in bold size 200 Arial font. This involved of a series of
pseudo-randomised consonants in both upper and lower
cases. The stimulus duration was 1000ms with a between
stimulus interval of 2000ms. Instructions were presented for
3000ms before each new 𝑛-back task.
fMRI data were acquired during three 9-minute runs.
0-back, 1-back, and 2-back tasks were presented in a ran-
domisedmanner resulting in six blocks per nine-minute run.
Each block consisted of 126 stimuli, one-third of which were
targets. Twice as many 0-back tasks were presented as 1-back
or 2-back. There was a rest period of 90 seconds between
blocks.
Statistical Analysis. The primary outcome was cognitive
performance as measured by improvement in SDMT, BVMT,
and CVLT between groups compared to baseline. Secondary
outcomes were QOL, fMRI, and QMT measures as detailed
below.
(i) Behavioural Data. Descriptive statistics for normally
distributed continuous variables are expressed as mean
and standard deviation. Skewed continuous variables were
summarised using median and interquartile range (IQR).
Categorical variables are summarised by frequencies and
percentages.
Normality of continuous variables was assessed using the
Kolmogorov-Smirnov test.
Baseline cognitive and behavioural measures were com-
pared between the treatment and control groups. Categorical
variables were compared by the Pearson 𝜒2 test.Themeans of
continuous variables were compared using the independent
samples 𝑡-test or the Mann–Whitney 𝑈 test for skewed data.
All tests were two-tailed; 𝑝-values less than 0.05 were
considered significant.
Outcomes were compared between the two groups using
independent samples 𝑡-test to compare gain scores for cog-
nitive data between groups. To compare differences between
groups for other behavioural and QOL data, a 2 × 3 repeat
measures analysis of variance (ANOVA)was usedwith “time”
as the within-subject factor and “treatment” as the between
factor (active rehabilitation versus control).
Analyses were performed using SPSS version 21
(Armonk, NY: IBM Corp).
(ii) Functional MRI Analysis. fMRI data were analysed using
SPM8 (Wellcome Department of Cognitive Neurology, UCL,
London, http://www.fil.ion.ucl.ac.uk/spm/).
For each time series, the first five EPIs were discarded
to ensure steady-state magnetisation. Individual EPIs were
then realigned to the first remaining image of the series by
rigid-body transformation to correct for involuntary head
movements during acquisition before normalisation into a
standard anatomical space (Montreal Neurological Institute
[MNI]) using linear and nonlinear transformations. Finally,
images were smoothed with an 8mm3 full-width-at-half-
maximum (FWHM) 3D Gaussian kernel.
First-Level Analysis. For each participant, the difference in
blood oxygen level-dependent (BOLD) response between the
0-back, 1-back, and 2-back conditions was estimated at every
voxel across the whole brain using the general linear model
(GLM).This produced a series of contrasts representingmean
activation during each 𝑛-back condition minus the 0-back
condition.
Second-Level Analysis. Each contrast obtained at the first-
level was entered into a second-level GLM to generate
summary statistical parametric maps (SPMs). For between-
group analysis of difference between the time points, we used
a 3× 2 ANOVAflexible factorial design with group (between-
subject) and time (within-subject) as separate factors to
examine themain effects on group (treatment versus control),
time and the interaction between them to evaluate areas
of relative change in activity after cognitive training versus
control.
The threshold for significance was set at alpha of 0.05
corrected formultiple comparisons (family-wise error (FWE)
corrected). Results are reported at cluster level throughout.
Within each region of statistical significance, the location of
local maxima of signal intensity increase is expressed as 𝑥, 𝑦,
and 𝑧 coordinates in MNI space.
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(iii) Quantitative MT Analysis. The MT data were analysed
using SPM8.MT and T1mapping data from all three sessions
were first realigned to subject specific MPRAGE structural
images using the SPM8 rigid-body registration function.
The MPRAGE were then segmented into white matter, grey
matter, and CSF to yield a parenchymal mask.
A T1 map was calculated for all datasets by fitting the
theoretical spoiled gradient echo as a function of the flip angle
to the signal measured by the 3D FLASH sequences [30].
MT parameters were obtained by performing a voxelwise
nonlinear least squares fitting (Levenberg-Marquardt) to a
binary spin bath model for bSSFP.
The statistical analysis was performed voxelwise in SPM8
on the resulting warped and smoothed MT maps. The same
GLMs used for the second-level fMRI analysis and described
in the previous section were used for estimating the main
effects of time and group and the interaction between these
two factors.
3. Results
Baseline Characteristics. 38 patients were included in the
study. The majority of the participants were female (71.1%).
At entry 27 patients (70.3%) had RRMS, and 11 patients
(29.7%) had SPMS. Patients were aged between 32 and 62
(mean 47.37, SD 8.23). The duration of MS from diagnosis
to enrolment ranged from 12 months to 40 years (mean
11.61 years, SD ± 8.2 yrs). Median EDSS was 5.0 (3.5–6.0).
20 patients (52.6%) were on disease modifying therapy at
enrolment (natalizumab 𝑛 = 6, beta-interferon 𝑛 = 7,
fingolimod 𝑛 = 6, and teriflunomide 𝑛 = 1).
After randomisation to either computer-assisted cogni-
tive training (treatment group, 𝑛 = 19) or the active control
condition (𝑛 = 19), there were no significant differences in
terms of baseline demographics (Table 1) or quality of life
measures (supplementary Table 3) between the two groups.
The treatment group had higher baseline cognitive scores
on the BICAMS battery; however, these did not differ signif-
icantly from the control group.
The most frequently failed component of the BICAMS
test battery was the SDMT with 33 (86.8%) of participants
scoring below the 5th centile, 18 (47.4%) failing the CVLT-
II, and 13 (34.2%) failing the BVMT-R. Overall 21 (55.2%)
failed one test, 10 (26.3%) failed two tests, and 7 (18.4%)
failed all three tests of the BICAMS test battery. This level of
impairment is consistent with other publishedMS samples on
BICAMS [31–33].
Overall, 88.9% of patients (16/18) in the intervention
group completed at least 75% of the prescribed sessions with
66.7% (12/18) completing all the prescribed sessions.
Behavioural Outcomes. The main behavioural outcomes are
shown in Table 2.
Time 2 versus Time 1. Compared to time 1, the treatment group
showed a significantly greater improvement in gain scores
between baseline and early follow-up (time 2) compared to
the control group on the SDMT (treatment 3.94 (SD 5.08),
Proportion of patients showing greater than 10% improvement
in SDMT immediately after intervention by group.
Percentage improvement in SDMT
SDMT% gain
Treatment Control
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Figure 1: Improvement in SDMT slope immediately after interven-
tion.
controls −0.63 (SD 3.30), 1.47 to 7.66, (95% CI 1.47 to 7.66), p
= 0.005) illustrated in Figure 1.
Similar gain scores in the CVLT and BVMT-R were
not significantly different between the groups although the
BVMT-R gain scores did approach significance (p = 0.098).
Cognitive Outcomes: Time 3 versus Time 1. Overall, there was
an improvement in BICAMSperformance across participants
at follow-up. The gain scores between the groups at time 3
compared to baseline were, however, not statistically signifi-
cantly different.
QOLOutcomes. At time 2 and time 3 there were no significant
differences in QOL outcome measures, measures of self-
efficacy, or subjective cognitive performance between the two
groups (supplementary Table 4).
N-Back Outcomes. The baseline error rate between the treat-
ment and control groups was low (8.64% versus 9.48%, p =
0.814). No significant differences were observed in the error
rate during the 𝑛-back task between the groups at baseline or
at follow-up (supplementary Table 5).
Functional MRI
Baseline: Main Effect of Task. The 𝑛-back task was associated
with robust activations of several cortical areas. The 1-back
task was associated with activations involving the dorsolat-
eral prefrontal cortex bilaterally as well as bilateral inferior
parietal lobule and insular and cerebellar regions relative to
the 0-back contrast. The same regions were activated in the
2-back condition but the spatial extent and magnitude of
the responses were greater, particularly over the frontopari-
etal regions (supplementary Figure 2 and supplementary
Table 2).
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Table 1: Baseline demographic characteristics and cognitive performance.
Treatment group (𝑛 = 19) Control group (𝑛 = 19) Mean difference (95% CI) p
Mean (SD) Mean (SD)
Age (years) 46.21 (6.59) 48.53 (9.63) −2.31 (−7.75 to 3.12) 0.588
Disease duration (years) 10.53 (6.13) 12.68 (9.87) −2.16 (−7.56 to 3.25) 0.424
EDSS 4.42 (1.75) 4.45 (1.77) −0.26 (−1.18 to 1.13) 0.964
Education (years) 14.05 (2.76) 13.63 (2.89) 0.42 (−1.43 to 2.28) 0.649
SDMT 43.39 (7.39) 38.21 (11.39) 5.18 (−1.27 to 11.63) 0.112
CLVT 45.32 (9.56) 43.89 (9.73) 1.42 (−4.93 to 7.77) 0.653
BVMT 20.63 (5.77) 18.05 (7.37) 2.58 (−1.77 to 6.93) 0.237
N/19 (%) N/19 (%) Odds ratio (95% CI) p
Gender (female) 13 (68.4) 14 (73.6) 0.74 (0.19 to 3.15) 0.721
Unemployed 13 (68.4) 11 (57.9) 1.58 (0.42 to 5.95) 0.501
Disease subtype
Relapsing-remitting 14 (73.6) 13 (68.4) 1.29 (0.32 to 5.28) 0.721
Secondary-progressive 5 (26.3) 6 (31.6)
On treatment at enrolment 12 (63.2) 8 (42.1) 2.38 (0.64 to 8.68) 0.194
Interferon∗ 5 2
Fingolimod 5 1
Natalizumab 2 4
Teriflunomide 0 1
∗ Includes Interferon (IF)-1b SC, IF-1A IM and IF-1A SC.
Table 2: BICAMS outcomes in treatment versus control groups.
Treatment (𝑛 = 17) Control (𝑛 = 18) Mean difference 95% CI p
Mean (SD) Mean (SD)
BICAMS improvement at follow-up (time 2 versus time 1)
SDMT gain 3.94 (5.08) −0.63 (3.30) 4.56 1.47 to 7.66 0.005
CVLT gain 6.67 (7.56) 4.06 (10.10) 2.71 −3.45 to 8.87 0.377
BVMT gain 4.65 (5.18) 1.94 (4.17) 2.70 −0.52 to 5.93 0.098
Treatment (𝑛 = 17) Control (𝑛 = 14) Mean difference 95% CI p
Mean (SD) Mean (SD)
BICAMS improvement at follow-up (time 3 versus time 1)
SDMT gain 3.35 (4.17) 4.57 (7.21) −1.28 −5.45 to 3.01 0.582
CVLT gain 6.94 (7.01) 7.50 (8.83) −0.56 −6.38 to 5.26 0.849
BVMT gain 7.29 (5.07) 4.14 (5.32) 3.15 −0.68 to 6.98 0.105
SDMT: Symbol Digits Modalities Test; CVLT: California Verbal Learning Test; BVMT: Brief Visuospatial Memory Test.
Time 2 versus Time 1. At time 2, increased activation was seen
in the right temporoparietal regions (right supramarginal and
angular gyri (𝑝 < 0.005FWE corrected at cluster level (𝑘 =
228))) in the 1-back in the treatment group relative to controls
(group-by-time interaction). No significant change was seen
in the 2-back task.
Time 3. At time 3 significant increases in activation were seen
in both the 1-back and 2-back conditions in the treatment
group relative to controls. In the 1-back task, increased
activation was seen in the left frontal (𝑝 < 0.001FWE corrected
at cluster level (𝑘 = 294)) and right temporoparietal regions
(𝑝 < 0.012FWE corrected at cluster level (𝑘 = 187)). In the
2-back task, increases in activation were seen in bilateral
prefrontal (𝑝 < 0.013FWE corrected at cluster level (𝑘 = 206))
and right temporoparietal regions (𝑝 < 0.024FWE corrected at
cluster level (𝑘 = 178)) (Figure 2).
Quantitative Magnetisation Transfer. No significant between-
group changes were seen in the QMT at time 2 or time 3, with
respect to time 1. Overall QMT measures showed stability
across all participants over the course of the study inmeasures
of all indices.
4. Discussion
In line with previouswork [8], themain outcome of this study
was that 6 weeks of computerised cognitive rehabilitation
was associated with improvement in cognitive performance
as measured on the SDMT. Significant alterations in brain
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Figure 2: Increased activations in treatment group relative to controls at follow-up. (a) Increased activation in treatment group in right
parietal region (white arrow, 𝑝 < 0.012FWE corrected) and left prefrontal region (dashed arrow, 𝑝 < 0.001FWE corrected). (b) Bilateral frontal gyrus
activation in treatment group relative to controls. Left MFG activation (arrow) significant at 𝑝 ≤ 0.042FWE corrected at cluster level (𝑘 = 152).
fMRI activations during the 𝑛-back task were also seen at
follow-up. The SDMT improvement in the treatment group
was, however, not maintained after cessation of cognitive
rehabilitation (time 3 assessments) although the functional
MRI changes were seen to persist at follow-up.
The SDMT is among the most sensitive tests of slowed
information processing speed in MS [34, 35] and may also
be a proxy for general cognitive impairment [36]. Compared
to time 1, the treatment group showed a significantly greater
improvement in gain scores between baseline and early
follow-up (time 2) compared to the control group on the
SDMT (p = 0.005). However, the gain scores between the
groups at time 3 compared to baseline were not statistically
significantly different. Overall, there was an improvement
in BICAMS performance across participants at follow-up.
It may be the case that cognitive rehabilitation does indeed
result in improved cognitive performance but that mainte-
nance of such improvement requires some form of ongoing
intervention in the longer term.The optimum frequency and
duration of cognitive training therefore remain unclear.
Clearly, repeat testing is potentially associated with prac-
tice effects. This may be particularly problematic when using
the same form of a test. Only one version of the BICAMS test
battery has been validated in MS and thus was used in this
study. Reported test-retest coefficients on the BICAMS tests
are excellent, suggesting that practice effects are negligible
[31, 32]. In addition, the experimental design was to compare
two groups with identical testing schedules; therefore the
impact of practice effects on the results is likely to beminimal.
QOL measures did not differ significantly between
groups. QOL is a complex construct influenced by a multi-
tude of factors such as employment status, social networks,
and perceptions of self-worth and self-efficacy. It is possible
that cognitive rehabilitation has a positive impact on a
number of these factors but such changes in such factors
may take time to manifest as improvements in QOL. Further
longitudinal analysis may be required to investigate this.
In order to minimise practice effects associated with
repeat testing, participants were not directly trained in the
𝑛-back task; rather it was utilised as an outcome measure
of working memory. It was anticipated that if cognitive
rehabilitation was effective at improving working memory
and attention, then the effects would be reflected on the
performance on the 𝑛-back task. No differences were seen in
the error rate between the groups during the 𝑛-back task at
follow-up; however, the error rate was low at baseline in both
groups.
The 𝑛-back fMRI paradigm in our study cohort was,
however, associated with robust baseline cortical activations
(in particular within the DLPFC and posterior parietal
cortex) in keeping with known working memory networks
[37]. A significant group-by-time interaction was seen with
the treatment group exhibiting increased activation in the
bilateral prefrontal cortex and right temporoparietal regions
relative to control group at time 3 (𝑝 < 0.05FWEcorr).
Changes in functional activation within these regions
within the treatment group are felt to be functionally relevant
with respect to cognitive rehabilitation. It has been shown
that the prefrontal cortex is critical in the executive control
of workingmemory and has a role in response inhibition [38,
39]. Effective organisation of workingmemorymay attenuate
task difficulty resulting in improvedworkingmemory perfor-
mance [38].
A right hemisphere dominant “ventral attentional net-
work” consisting of the temporoparietal junction, ventral pre-
frontal cortex, and anterior insula is thought to be responsible
for directing attention to salient events [40]. Previous work
inMS has indicated that attentionmay be one of the domains
most amenable to rehabilitation [8]. Many of the computer-
training tasks involve sustained attention and it might be
postulated that the increased activation seen in the right
temporoparietal region at follow-up in the treatment group
is as a result of improved efficiency of this network.
Interestingly, the evolution of much activity on fMRI
developed after cessation of the active intervention phase.
It is likely the case that solidification of neural networks
occurs with training. This solidification of neural networks
may extend to areas/networks outside those directly trained
and may explain why working memory centres such as the
prefrontal cortex were seen to be persistently active after
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cessation of formal training [41]. Debate remains however as
to the possible interplay between adaptive and maladaptive
responses during functional brain reorganisation [14].
The discrepancy between the apparent lack of clinical
difference between the groups at time 3 and the sustained
fMRI effect at time 3 may reflect the fact that BICAMS does
not adequately measure working memory which is primarily
domain utilised during the 𝑛-back fMRI paradigm.
Some studies have identified structural changes on diffu-
sion tensor imaging as a result of rehabilitation in the context
of physiotherapy [42, 43]. Our study attempted to explore
the role of myelin in rehabilitation and repair. We did not
detect any structural change on QMT after training. Due to
the short duration of follow-up, this is not entirely surprising.
Functional alterations in cortical activity may subsequently
modulate brain structure at the microstructural level but
such changes in structural brain architecture might only be
detectable over the longer term.
In contrast to many previous studies, which often rely
on one-to-one or outpatient administered cognitive reha-
bilitation, this study sought to explore whether a home-
based approach to cognitive rehabilitation was feasible. The
compliance rate of those undertaking the rehabilitation was
excellent. A home-based approach to cognitive rehabilitation
is significantly less resource intensive and may pave the way
to greater access for a greater number of patients to such
interventions in the future.
Limitations. This work has some limitations. Firstly, the
groups were relatively small and there was a dropout of
patients mainly in the control group between time 2 and
time 3. There was heterogeneity with regard to the cognitive
domains that showed deficits among participants in the study.
It is likely therefore that theymay not have benefited from the
rehabilitation in the same way. Unfortunately the sample size
of the study is too small to perform subgroup analysis.
As the study was largely exploratory in nature, it utilised
an open design and is therefore subject to a number of
limitations inherent to this type of design. For pragmatic
reasons blinding of the investigating neurologist was not
established due to the potential need for interaction between
patient and investigator. This does present the potential for
observer bias, particularly where repeat testing is required.
SPM analysis of MRI data offers objective, largely auto-
mated measures, which are independent of measurement
bias. Investigator blinding was maintained for any methods
such as assessment of white matter lesion volumes that
involved manual interpretation.
In many respects, the SDMT may provide a proxy for
overall cognitive functioning [44] but a more detailed cog-
nitive assessment of the domains directly trained may have
provided additional insight into effectiveness of cognitive
training. BICAMS is primarily designed as a screening tool
for cognitive impairment in MS assessing a limited number
of domains. However, strong ecological validity has been
demonstrated in relation to everyday task performance and
employment, suggesting that the three domains are strongly
predictive of comprehensive real-world performance [45, 46].
BICAMS may not necessarily be sensitive to change over the
short-term, although the reported test-retest coefficients are
excellent which would suggest sensitivity over this period
[31, 32, 47].
It is postulated that alterations in fMRI activity result
from microstructural changes. The lack of significant
change in QMT measurements, however, suggests that
the microstructural changes thought to underpin adaptive
responses may, at present, be beyond the resolution of even
the most advanced MRI techniques or not manifest within
the timescale of this study. Additional follow-up of this
cohort is planned to determine what, if any, changes are
observed in terms of both cortical activation as measured
by fMRI and structural changes measurable with QMT.
Longer-term studies may also provide insight into the
true functional impact of cognitive rehabilitation such as
maintenance of employment.
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